Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide

Ayalew Tefferi, Natasha Szuber, Rangit R. Vallapureddy, Kebede H. Begna, Mrinal M. Patnaik, Michelle A. Elliott, C. Christopher Hook, Alexandra P. Wolanskyj, Curtis A. Hanson, Rhett P. Ketterling, Animesh Pardanani, Naseema Gangat

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide'. Together they form a unique fingerprint.

Medicine & Life Sciences